Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06877637
What this trial is testing

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Region Skane 150
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Large-scale testing (Phase 3)UnknownNCT02186574
What this trial is testing

Tenofovir to Prevent HBV Reactivation

Who this might be right for
Hepatitis BLymphomaNon-Hodgkin
University Health Network, Toronto 184
Testing effectiveness (Phase 2)WithdrawnNCT03484962
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Active Not RecruitingNCT04658147
What this trial is testing

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Testing effectiveness (Phase 2)Study completedNCT00885885
What this trial is testing

Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 80
Not applicableLooking for participantsNCT05199259
What this trial is testing

Multi-analyte Blood Test Clinical Trial

Who this might be right for
Liver CirrhosisLiver CancerHCC+1 more
Helio Genomics 1,200
Not applicableStudy completedNCT04257240
What this trial is testing

Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury

Who this might be right for
Ischemic Reperfusion InjuryLiver InjuryCancer Recurrence+2 more
Aretaieion University Hospital 230
Not applicableStudy completedNCT02582918
What this trial is testing

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

Who this might be right for
Carcinoma, HepatocellularLiver Neoplasms
University of Texas Southwestern Medical Center 2,871
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Testing effectiveness (Phase 2)Looking for participantsNCT07479485
What this trial is testing

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Who this might be right for
Hepatocellular Carcinoma
Lepu Biopharma Co., Ltd. 160
Post-approval studies (Phase 4)UnknownNCT01564810
What this trial is testing

Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisLiver Neoplasms
Xu jianmin 150
Testing effectiveness (Phase 2)Study completedNCT03757858
What this trial is testing

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Who this might be right for
CancerAbdominal CancerPelvic Cancer+3 more
Capital Medical University 40
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Not applicableStudy completedNCT02983968
What this trial is testing

Use of the French Healthcare Insurance Database

Who this might be right for
Cirrhosis
Centre Hospitalier Universitaire, Amiens 75,868
Not applicableUnknownNCT05627297
What this trial is testing

Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Next Page